Biomarkers in anal cancer: from biological understanding to stratified treatment

被引：45
作者：
Jones, Christopher M. [1 ,2 ]
Goh, Vicky [3 ,4 ]
Sebag-Montefiore, David [1 ,2 ]
Gilbert, Duncan C. [5 ]
机构：
[1] Leeds Teaching Hosp NHS Trust, Leeds Canc Ctr, Leeds LS9 7TF, W Yorkshire, England
[2] Univ Leeds, Leeds Inst Canc & Pathol, Leeds LS9 7TF, W Yorkshire, England
[3] Kings Coll London, Div Imaging Sci & Biomed Engn, London SE1 7EH, England
[4] Guys & St Thomas NHS Fdn Trust, Dept Radiol, London SE1 7EH, England
[5] Royal Sussex Cty Hosp, Sussex Canc Ctr, Eastern Rd, Brighton BN2 5BE, E Sussex, England
来源：
BRITISH JOURNAL OF CANCER | 2017年 / 116卷 / 02期
关键词：
anal cancer; chemoradiotherapy; HPV; squamous cell carcinoma of the anus; human papilloma virus; biomarkers; SQUAMOUS-CELL CARCINOMA; HUMAN-PAPILLOMAVIRUS; NECK-CANCER; SURVIVAL; MUTATIONS; CHEMORADIOTHERAPY; P16(INK4A); EXPRESSION; REVEALS; HEAD;
D O I：
10.1038/bjc.2016.398
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Squamous cell carcinomas of the anus and anal canal represent a model of a cancer and perhaps the first where level 1 evidence supported primary chemoradiotherapy (CRT) in treating locoregional disease with curative intent. The majority of tumours are associated with infection with oncogenic subtypes of human papilloma virus and this plays a significant role in their sensitivity to treatment. However, not all tumours are cured with CRT and there remain opportunities to improve outcomes in terms of oncological control and also reducing late toxicities. Understanding the biology of ASCC promises to allow a more personalised approach to treatment, with the development and validation of a range of biomarkers and associated techniques that are the focus of this review.
引用
收藏
页码：156 / 162
页数：7
相关论文
共 50 条
  • [31] Anal cancer: Focus on current treatment and future perspective
    Delhiat, A. C.
    Combet-Curt, V.
    Vendrely, V.
    CANCER RADIOTHERAPIE, 2022, 26 (6-7): : 871 - 874
  • [32] FDG-PET parameters predict for recurrence in anal cancer - results from a prospective, multicentre clinical trial
    Jones, Michael Peter
    Hruby, George
    Metser, Ur
    Sridharan, Swetha
    Capp, Anne
    Kumar, Mahesh
    Gallagher, Sarah
    Rutherford, Natalie
    Holder, Carl
    Oldmeadow, Christopher
    Martin, Jarad
    RADIATION ONCOLOGY, 2019, 14 (01)
  • [33] Anal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    Rao, S.
    Guren, M. G.
    Khan, K.
    Brown, G.
    Renehan, A. G.
    Steigen, S. E.
    Deutsch, E.
    Martinelli, E.
    Arnold, D.
    ANNALS OF ONCOLOGY, 2021, 32 (09) : 1087 - 1100
  • [34] Treatment outcomes and prognostic factors after chemoradiotherapy for anal cancer
    Slordahl, Kathinka S.
    Klotz, Dagmar
    Olsen, Jan-Age
    Skovlund, Eva
    Undseth, Christine
    Abildgaard, Heidi Larsen
    Braendengen, Morten
    Nesbakken, Arild
    Larsen, Stein Gunnar
    Hanekamp, Bettina A.
    Holmboe, Laila
    Tvedt, Ragnhild
    Sveen, Anita
    Lothe, Ragnhild A.
    Malinen, Eirik
    Kaasa, Stein
    Guren, Marianne Gronlie
    ACTA ONCOLOGICA, 2021, 60 (07) : 921 - 930
  • [35] Survival study in early stages of glottis cancer, stratified by treatment
    Lois-Ortega, Yolanda
    Garcia-Curdi, Fernando
    Valles-Varela, Hector
    Muniesa-del Campo, Ana
    ACTA OTO-LARYNGOLOGICA, 2022, 142 (7-8) : 627 - 633
  • [36] Unraveling Emerging Anal Cancer Clinical Biomarkers from Current Immuno-Oncogenomics Advances
    Iseas, Soledad
    Mariano, Golubicki
    Gros, Louis
    Baba-Hamed, Nabil
    De Parades, Vincent
    Adam, Julien
    Raymond, Eric
    Abba, Martin Carlos
    MOLECULAR DIAGNOSIS & THERAPY, 2024, 28 (02) : 201 - 214
  • [37] Clinical characteristics and prognosis of anal squamous cell carcinoma: a retrospective audit of 144 patients from 11 cancer hospitals in southern China
    Lu, Yong
    Wang, Xiaohao
    Li, Peiyang
    Zhang, Tao
    Zhou, Jiaming
    Ren, Yufeng
    Ding, Yi
    Peng, Haihua
    Wei, Qichun
    You, Kaiyun
    Ong, Jason J.
    Fairley, Christopher K.
    Grulich, Andrew E.
    Huang, Meijin
    Gao, Yuanhong
    Zou, Huachun
    BMC CANCER, 2020, 20 (01)
  • [38] Stridor: an unexpected complication from chemoradiotherapy for anal cancer
    Moe, M. M.
    Askill, C.
    JOURNAL OF THE ROYAL COLLEGE OF PHYSICIANS OF EDINBURGH, 2009, 39 (04) : 313 - 314
  • [39] RETRACTED: Retracted: Identification of Prognosis Biomarkers of Prostatic Cancer in a Cohort of 498 Patients from TCGA (Retracted Article)
    Chen, Zhiqiang
    Hu, Haiyi
    JOURNAL OF COMPUTATIONAL BIOLOGY, 2020, 26 (12) : E1487 - E1498
  • [40] Effective treatment of anal cancer in the elderly with low-dose chemoradiotherapy
    N Charnley
    A Choudhury
    P Chesser
    R A Cooper
    D Sebag-Montefiore
    British Journal of Cancer, 2005, 92 : 1221 - 1225
12345